Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001736730-25-000098
Filing Date
2025-11-10
Accepted
2025-11-10 17:12:55
Documents
23

Document Format Files

Seq Description Document Type Size
1 S-3 camp4therapeutics-atmsx3.htm S-3 425946
2 camp4111025exfilingfees.htm   iXBRL EX-FILING FEES 33833
3 EX-1.2 exhibit12-atmsx3.htm EX-1.2 298811
4 EX-4.8 exhibit48-atmsx3.htm EX-4.8 352992
5 EX-5.1 exhibit51-atmsx3.htm EX-5.1 18100
6 EX-5.2 exhibit52-atmsx3.htm EX-5.2 8364
7 EX-23.3 exhibit233-atmsx3.htm EX-23.3 2160
8 EX-25.1 exhibit251-atmsx3.htm EX-25.1 131097
9 exhibit251a.jpg GRAPHIC 295512
10 prospectusa.jpg GRAPHIC 22380
11 ropesa.jpg GRAPHIC 14827
12 ropesgraya.jpg GRAPHIC 14827
13 ropesgrayllpa.jpg GRAPHIC 1903
  Complete submission text file 0001736730-25-000098.txt   1886833

Data Files

Seq Description Document Type Size
25 EXTRACTED XBRL INSTANCE DOCUMENT camp4111025exfilingfees_htm.xml XML 8736
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Filer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-291432 | Film No.: 251467364
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)